UA108473C2 - Conjugates, their preparation and therapeutic use - Google Patents

Conjugates, their preparation and therapeutic use

Info

Publication number
UA108473C2
UA108473C2 UAA201200825A UAA201200825A UA108473C2 UA 108473 C2 UA108473 C2 UA 108473C2 UA A201200825 A UAA201200825 A UA A201200825A UA A201200825 A UAA201200825 A UA A201200825A UA 108473 C2 UA108473 C2 UA 108473C2
Authority
UA
Ukraine
Prior art keywords
group
alkyl group
phenyl core
alkyl
substituent
Prior art date
Application number
UAA201200825A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ерве Бушар
Марі-Прісцилл Брен
Ален Коммерсон
Цзідун Чжан
Original Assignee
Санофі
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0903170A external-priority patent/FR2947269B1/en
Application filed by Санофі filed Critical Санофі
Publication of UA108473C2 publication Critical patent/UA108473C2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/08Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and more than one oxygen atom

Abstract

The invention relates to a targeting agent, to which at least one cryptophycin is attached of the formula (I), where: R1 is a halogen atom and R2 is an -OH group, an acyl group derived from an amino acid AA or a (C1-C4)alkanoyloxy group; or else R1 and R2 together form an epoxy unit; AA denotes a natural or artificial amino acid; R3 is a (C1-C6)alkyl group; R4 and R5 are both H or together form a CH=CH double bond between C13 and C14; R6 and R7 are, independently from one another, H or a (C1-C6)alkyl group; R8 and R9 are, independently from one another, H or a (C1-C6)alkyl group; R10 is at least one substituent of the phenyl core selected from among: H, an -OH group, (C1-C4)alkoxy, a halogen atom or a -NH2, -NH(C1-C6)alkyl, or -N(C1-C6)alkyl group; R11 is at least one substituent of the phenyl core selected from among H or a (C1-C4)alkyl group; the targeting agent and the cryptophycin derivative being covalently bonded, the bond being located at the ortho- (o), meta- (m), or para- (p) position of the phenyl core containing the CR1 unit.
UAA201200825A 2009-06-29 2010-05-20 Conjugates, their preparation and therapeutic use UA108473C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0903170A FR2947269B1 (en) 2009-06-29 2009-06-29 NEW ANTICANCER COMPOUNDS
FR0905651A FR2947271B1 (en) 2009-06-29 2009-11-25 NEW ANTICANCER COMPOUNDS
PCT/FR2010/050986 WO2011001052A1 (en) 2009-06-29 2010-05-20 Novel conjugates, preparation thereof, and therapeutic use thereof

Publications (1)

Publication Number Publication Date
UA108473C2 true UA108473C2 (en) 2015-05-12

Family

ID=65686635

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201200825A UA108473C2 (en) 2009-06-29 2010-05-20 Conjugates, their preparation and therapeutic use

Country Status (1)

Country Link
UA (1) UA108473C2 (en)

Similar Documents

Publication Publication Date Title
MX2011013764A (en) Novel conjugates, preparation thereof, and therapeutic use thereof.
MX2009002802A (en) 2-aryl-6-phenylimidazo[1,2-î±]pyridine derivatives, preparation thereof and therapeutic use thereof.
EA201171328A1 (en) Derivative Isoquinoline Derivative
MX2012015023A (en) Novel nicotinamide derivatives or salts thereof.
NO20041891L (en) Amide derivatives such as glycogen synthase kinase 3beta inhibitors
PE20140863A1 (en) BENZENE COMPOUNDS REPLACED WITH ARYL OR HETEROARYL
MX2012001399A (en) Prodrugs comprising an insulin linker conjugate.
MX2011009146A (en) Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as dhodh inhibitors.
MY153044A (en) Tetrahydroquinoline derivatives for treating post-traumatic stress disorders
MX2011007772A (en) Isoxazole / o-pyridine derivatives with ethyl and ethenyl linker.
CO6020016A1 (en) DERIVATIVES OF 1,2,4,5 TETRAHIDRO-3H-BENZAPEZINAS ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY29023A1 (en) PROCEDURE FOR PREPARATION OF DERIVATIVES N- PIPERIDINO - 1, 5 - DIFENILPIRAZOL - 3 - CARBOXAMIDA.-
CY1111601T1 (en) TRIAZOLOPYRIDINE CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
HUP0303279A2 (en) Indolylopyrrolocarbazoles sugar derivatives as topoisomerase inhibitors and pharmaceutical compositions containing them
MX2010004442A (en) Novel precursors.
UA108473C2 (en) Conjugates, their preparation and therapeutic use
MX2009013775A (en) Novel substituted piperidones as hsp inducers.
IN2013MN00506A (en)
EA201070196A1 (en) DERIVATIVES 1-OXO-1,2-dihydroisoquinoline-5-carboxamides and 4-oxo-3,4-dihydroquinazoline-8-carboxamides, THEIR RECEPTION AND THEIR APPLICATION IN THERAPY
EA201070819A1 (en) COMPOUNDS OF N-PHENYLIMIDAZO [1,2-A] PYRIDIN-2-CARBOXAMIDE, THEIR PRODUCTION AND THEIR APPLICATION IN THERAPY
UA88766C2 (en) Quinoline derivatives for the treatment of latent tuberculosis
MY151167A (en) Benzimidazole compound
TW200942538A (en) 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof
TN2010000525A1 (en) Phenyl or pyridinyl substututed indazoes derivatives
EA201390857A1 (en) ANALGEZING COMPOUNDS, METHODS AND COMPOSITIONS